 On Thursday, President Joe Biden revealed his new COVID-19 action plan, which includes 2 billion in government spending on 280 million rapid point of care and at-home COVID-19 tests. On Friday, Bank of America analyst Bob Hopkins said Bidens new plan is good news for test manufacturers, including Becton Dickinson and Co NYSE:BDX and Abbott Laboratories NYSE:ABT. 